Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,845 total articles

Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
Apr 8, 2026
Ajmal Hussain
Press Releases

Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles

Invivyd announces progress in its Phase 3 pivotal DECLARATION study of VYD2311 for COVID-19 prevention, including a sample size increase to enhance statistical power and a slight delay in expected top-line results to Q3 2026. The company also reveals discovery and rapid development plans for VMS063, a novel, potentially first- and best-in-class mon…

IVVD
Occidental Announces Gulf of America Oil Discovery at Bandit
Apr 8, 2026
Maya Rios
Press Releases

Occidental Announces Gulf of America Oil Discovery at Bandit

Occidental Petroleum Corporation reported a new oil discovery at the Bandit prospect located about 125 miles south of Louisiana in the Gulf of America. The discovery involves high-quality, full-to-base oil-bearing Miocene sands and offers potential subsea infrastructure tie-backs to existing nearby facilities. Occidental, which operates the site an…

OXY
Nkarta to Participate in Needham Virtual Healthcare Conference
Apr 8, 2026
Hana Yamamoto
Press Releases

Nkarta to Participate in Needham Virtual Healthcare Conference

Nkarta, Inc., a clinical-stage biopharmaceutical company specializing in engineered natural killer (NK) cell therapies for autoimmune diseases, announced its participation in the 25th Annual Needham Virtual Healthcare Conference. Company executives will discuss their investigational CAR-NK cell therapy targeting B cell-mediated autoimmune diseases …

NKTX
Seres Therapeutics to Present at CARB-X Investor Day
Apr 8, 2026
Sofia Navarro
Press Releases

Seres Therapeutics to Present at CARB-X Investor Day

Seres Therapeutics announced its presentation at the 2026 CARB-X Investor Day, underscoring its ongoing collaboration with CARB-X to develop novel live biotherapeutics targeting antimicrobial resistance (AMR). The company highlighted its advancement of SER-428, an oral liquid formulation intended for ICU patients at high risk of AMR infections, sup…

MCRB
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
Apr 8, 2026
Sofia Navarro
Press Releases

Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate

Kymera Therapeutics announced that Gilead Sciences has exercised its option to exclusively license KT-200, a novel oral CDK2 molecular glue degrader developed by Kymera. This triggers a $45 million milestone payment to Kymera, with Gilead advancing the program toward IND-enabling studies for a potential 2027 IND filing. KT-200 offers a targeted the…

KYMR
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
Apr 8, 2026
Priya Menon
Press Releases

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Rani Therapeutics, a clinical-stage biotherapeutics company listed on Nasdaq, announced the appointment of Dr. Sara Kenkare-Mitra as Strategic Advisor. Dr. Kenkare-Mitra brings extensive expertise in biologics development and will support the advancement of Rani's oral biologics platform, including their RaniPill technology and programs such as ora…

RANI
ScottsMiracle-Gro Completes Divestiture of Hawthorne Subsidiary
Apr 8, 2026
Sofia Navarro
Press Releases

ScottsMiracle-Gro Completes Divestiture of Hawthorne Subsidiary

The Scotts Miracle-Gro Company has finalized the divestiture of its subsidiary, The Hawthorne Gardening Company, to cannabis operator Vireo Growth. The transaction supports ScottsMiracle-Gro's strategy to concentrate on its core lawn and garden products, with no impact on its full fiscal 2026 guidance. The company expects the divestiture to aid mar…

SMG
Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
Apr 8, 2026
Maya Rios
Press Releases

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Foghorn Therapeutics announced upcoming presentations of new preclinical data for its selective SMARCA2 inhibitor FHD-909 and other degrader programs targeting CBP, EP300, and ARID1B at the 2026 AACR Annual Meeting. The data suggest potential expansion opportunities for combination therapies in various cancer types, reinforcing the company's innova…

FHTX
Biodesix Recognized as a Top Workplace for Third Consecutive Year
Apr 8, 2026
Derek Hwang
Press Releases

Biodesix Recognized as a Top Workplace for Third Consecutive Year

Biodesix has been recognized as a 2026 USA TODAY Top Workplaces award winner for the third consecutive year, a designation based on direct employee feedback regarding workplace experience and culture. The award reflects Biodesix's commitment to a people-first culture that fosters trust, collaboration, and accountability, supporting its mission to i…

BDSX
The Simply Good Foods Company Reports Fiscal Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Outlook
Apr 8, 2026
Nina Shah
Press Releases

The Simply Good Foods Company Reports Fiscal Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Outlook

The Simply Good Foods Company reported a net loss of $159.7 million for Q2 fiscal 2026, a significant decline from net income in the prior year period. Net sales declined by 9.4%, driven by poor performances in Atkins and OWYN brands, partially offset by slight Quest growth. The company took a $249 million non-cash impairment charge on Atkins and O…

SMPL
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
Apr 8, 2026
Maya Rios
Press Releases

C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)

C4 Therapeutics has entered a new collaboration agreement with Roche focused on developing degrader-antibody conjugates (DACs) for cancer treatment. The deal involves leveraging C4T's TORPEDO platform to design novel degrader payloads and Roche's expertise in antibody-drug conjugation to create and advance DAC candidates. C4T will receive a $20 mil…

CCCC
Toll Brothers Announces Final Opportunity to Build a New Luxury Home at NorthGrove - Villa Collection in Magnolia, Texas
Apr 8, 2026
Caleb Monroe
Press Releases

Toll Brothers Announces Final Opportunity to Build a New Luxury Home at NorthGrove - Villa Collection in Magnolia, Texas

Toll Brothers Inc., a leading luxury home builder, announces the final opportunity to buy homes in the NorthGrove - Villa Collection community in Magnolia, Texas. The community offers luxury homes with resort-style amenities, set in a master-planned neighborhood close to major highways and schools. Homes are priced from the upper $300,000s with var…

TOL
HII Hosts PAE Maritime Christopher Miller at Ingalls Shipbuilding
Apr 8, 2026
Sofia Navarro
Press Releases

HII Hosts PAE Maritime Christopher Miller at Ingalls Shipbuilding

HII welcomed Christopher Miller, the U.S. Navy's portfolio acquisition executive for maritime, at its Ingalls Shipbuilding division. The visit highlighted Ingalls' recent investments exceeding $1 billion in infrastructure and technology to support current and future Navy shipbuilding programs, including destroyers and amphibious assault ships. The …

HII
Weight Watchers Announces Board Committee Appointments
Apr 8, 2026
Leila Farooq
Press Releases

Weight Watchers Announces Board Committee Appointments

Weight Watchers announced updates to its Board of Directors committees following the appointment of two new independent directors. The company confirmed that it will not appoint an interim CEO but will continue under its existing Office of the CEO structure during the search for a permanent CEO.

WW
AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 Firm
Apr 8, 2026
Derek Hwang
Press Releases

AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 Firm

AGA Precision Systems, a subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), announced a second long-term agreement with a globally recognized Tier 1 aerospace and defense company to supply precision CNC-manufactured components. This agreement reinforces AGA's position as a qualified supplier within the U.S. defense supply chain and supports recurring…

ELAB